切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2022, Vol. 16 ›› Issue (01) : 8 -11. doi: 10.11817/j.issn.1673-9248.2022.01.002

专家论坛

不同空间分布脑微出血的常见病因和影像学特征的研究进展
胡红梅1, 胡文立1,()   
  1. 1. 100020 首都医科大学附属北京朝阳医院神经内科
  • 收稿日期:2021-10-28 出版日期:2022-02-01
  • 通信作者: 胡文立
  • 基金资助:
    国家自然科学基金(81271309)

Research progress in common etiology and imaging features of cerebral microbleeds with different spatial distribution

Hongmei Hu1, Wenli Hu1,()   

  1. 1. Department of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
  • Received:2021-10-28 Published:2022-02-01
  • Corresponding author: Wenli Hu
引用本文:

胡红梅, 胡文立. 不同空间分布脑微出血的常见病因和影像学特征的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2022, 16(01): 8-11.

Hongmei Hu, Wenli Hu. Research progress in common etiology and imaging features of cerebral microbleeds with different spatial distribution[J/OL]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2022, 16(01): 8-11.

脑微出血是脑小血管病的典型影像学表现之一。随着MRI技术的进一步发展,脑微出血的检出率显著提高,其分布特点、数量及临床意义各不相同。脑微出血的病理生理机制尚不完全清楚,可能继发于长期高血压或组织中淀粉样蛋白沉积对血管壁的损伤。识别脑微出血的起源取决于患者的病史和临床表现、脑微出血的定位以及其他相关MRI异常的存在,对于其临床相关疾病的诊疗决策具有重要意义。本文就不同空间分布脑微出血的流行病学、常见病因、影像学特征的研究进展及临床意义进行总结,以期更好地指导临床诊断。

Cerebral microbleeds (CMB) is one of the typical imaging manifestations of cerebral small vessel disease. With the development of MRI technology, significantly more CMB have been detected, showing different distribution, number and clinical significance. The pathophysiological mechanism of CMB is not fully clear and may be secondary to vascular injury caused by chronic hypertension or amyloid deposition in tissues. Identifying the origin of CMB depends on the patient's medical history and clinical manifestations, the location of CMB, and the presence of other related MRI abnormalities, which is of great significance for diagnosis and treatment decisions of CMB-related diseases. This article reviews the epidemiology, etiology, imaging features, and clinical significance of CMB with different spatial distribution.

1
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration [J]. Lancet Neurol, 2013, 12(8): 822-838.
2
Wilson D, Ambler G, Lee K, et al. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies [J]. Lancet Neurol, 2019, 18(7): 653-665.
3
Lee J, Sohn EH, Oh E, et al. Characteristics of cerebral microbleeds [J]. Dement Neurocogn Disord, 2018, 17(3): 73-82.
4
Poels MMF, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study [J]. Stroke, 2010, 41(10 Suppl): S103-S106.
5
Lu D, Liu J, Mackinnon AD, et al. Prevalence and risk factors of cerebral microbleeds: an analysis from the UK biobank [J]. Neurology, 2021. Online ahead of print.
6
Yakushiji Y, Wilson D, Ambler G, et al. Distribution of cerebral microbleeds in the East and West: Individual participant meta-analysis [J]. Neurology, 2019, 92(10): e1086-e1097.
7
Gregoire SM, Chaudhary UJ, Brown MM, et al. The microbleed anatomical rating scale (MARS): reliability of a tool to map brain microbleeds [J]. Neurology, 2009, 73(21): 1759-1766.
8
Charidimou A, Boulouis G, Gurol ME, et al. Emerging concepts in sporadic cerebral amyloid angiopathy [J]. Brain, 2017, 140(7): 1829-1850.
9
Linn J, Halpin A, Demaerel P, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy [J]. Neurology, 2010, 74(17): 1346-1350.
10
Tsai H, Pasi M, Tsai L, et al. Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: a PiB-PET study [J]. Neurology, 2019, 92(8): e774-e781.
11
Shams S, Wahlund L. Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field [J]. Biomark Med, 2016, 10(1): 9-18.
12
Akoudad S, Wolters FJ, Viswanathan A, et al. Association of cerebral microbleeds with cognitive decline and dementia [J]. JAMA Neurology, 2016, 73(8): 934-943.
13
Cordonnier C, van der Flier WM. Brain microbleeds and Alzheimer's disease: innocent observation or key player? [J]. Brain, 2011, 134(Pt 2): 335-344.
14
McKinney AM, Sarikaya B, Gustafson C, et al. Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging [J]. AJNR Am J Neuroradiol, 2012, 33(5): 896-903.
15
Champey J, Pavese P, Bouvaist H, et al. Value of brain MRI in infective endocarditis: a narrative literature review [J]. Eur J Clin Microbiol Infect Dis, 2016, 35(2): 159-168.
16
Okazaki S, Sakaguchi M, Hyun B, et al. Cerebral microbleeds predict impending intracranial hemorrhage in infective endocarditis [J]. Cerebrovasc Dis, 2011, 32(5): 483-488.
17
Griffin AD, Turtzo LC, Parikh GY, et al. Traumatic microbleeds suggest vascular injury and predict disability in traumatic brain injury [J]. Brain, 2019, 142(11): 3550-3564.
18
Puy L, Pasi M, Rodrigues M, et al. Cerebral microbleeds: from depiction to interpretation [J]. J Neurol Neurosurg Psychiatry, 2021, 92(6): 598-607.
19
Morrison MA, Hess CP, Clarke JL, et al. Risk factors of radiotherapy-induced cerebral microbleeds and serial analysis of their size compared with white matter changes: a 7T MRI study in 113 adult patients with brain tumors [J]. J Magn Reson Imaging, 2019, 50(3): 868-877.
20
孙浩耕, 任宇涛, 肖安琪, 等. 烟雾病患者脑微出血的临床特点分析 [J/OL]. 中华脑血管病杂志(电子版), 2021, 15(4): 247-252.
21
Haller S, Vernooij MW, Kuijer JPA, et al. Cerebral microbleeds: imaging and clinical significance [J]. Radiology, 2018, 287(1): 11-28.
22
Pasi M, Pongpitakmetha T, Charidimou A, et al. Cerebellar microbleed distribution patterns and cerebral amyloid angiopathy [J]. Stroke, 2019, 50(7): 1727-1733.
23
Jung YH, Jang H, Park SB, et al. Strictly lobar microbleeds reflect amyloid angiopathy regardless of cerebral and cerebellar compartments [J]. Stroke, 2020, 51(12): 3600-3607.
24
Di Donato I, Bianchi S, De Stefano N, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects [J]. BMC Med, 2017, 15(1): 41.
25
Kono Y, Wakabayashi T, Kobayashi M, et al. Characteristics of cerebral microbleeds in patients with fabry disease [J]. J Stroke Cerebrovasc Dis, 2016, 25(6): 1320-1325.
26
Giyab O, Balogh B, Bogner P, et al. Microbleeds show a characteristic distribution in cerebral fat embolism [J]. Insights Imaging, 2021, 12(1): 42.
27
Deb-Chatterji M, Schuster S, Haeussler V, et al. Primary angiitis of the central nervous system: new potential imaging techniques and biomarkers in blood and cerebrospinal fluid [J]. Front Neurol, 2019, 10: 568.
28
Hwang J, Caturegli G, White B, et al. Cerebral microbleeds and intracranial hemorrhages in adult patients on extracorporeal membrane oxygenation-autopsy study [J]. Crit Care Explor, 2021, 3(3): e0358.
29
Fanou EM, Coutinho JM, Shannon P, et al. Critical illness-associated cerebral microbleeds [J]. Stroke, 2017, 48(4): 1085-1087.
30
Cordonnier C, Potter GM, Jackson CA, et al. improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS) [J]. Stroke, 2009, 40(1): 94-99.
31
Al-Masni MA, Kim W, Kim EY, et al. Automated detection of cerebral microbleeds in MR images: a two-stage deep learning approach [J]. Neuroimage Clin, 2020, 28: 102464.
32
Charidimou A, Blacker D, Viswanathan A. Context is everything: from cardiovascular disease to cerebral microbleeds [J]. Int J Stroke, 2018, 13(1): 6-10.
33
Ding J, Sigurðsson S, Jónsson PV, et al. Space and location of cerebral microbleeds, cognitive decline, and dementia in the community [J]. Neurology, 2017, 88(22): 2089-2097.
34
Wilson D, Ambler G, Lee K, et al. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic [J]. Lancet Neurol, 2019, 18(7): 653-665.
35
Henneman WJP, Sluimer JD, Cordonnier C, et al. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population [J]. Stroke, 2009, 40(2): 492-498.
[1] 陈嘉婷, 杜美君, 石冰, 黄汉尧. 母体系统性疾病对新生儿唇腭裂发生的影响[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 262-268.
[2] 刘起帆, 蒋安. 肝硬化门静脉高压症门静脉压力无创测量进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 270-275.
[3] 杨竞, 周光文. 肝硬化门静脉高压症治疗后再出血危险因素分析及预测模型构建[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 296-301.
[4] 刘国龙, 王鹏, 谭超, 杨辉, 彭菊红. 神经外科机器人辅助双通道颅内血肿清除术治疗高血压性脑出血[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 254-256.
[5] 张轩, 冯明, 王倩, 薛蓉. 舒脑欣滴丸对脑小血管病患者客观睡眠和炎症标志物的影响[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(03): 140-145.
[6] 景方坤, 周建波, 王全才, 黄海韬, 李岩峰, 徐杨熙. 神经导航引导下治疗基底节高血压脑出血的短期疗效预测[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(03): 154-159.
[7] 刘鑫, 裴思雨, 李志强, 陈成文, 傅硕, 卢领, 孙楠楠, 程守全, 谢冰, 张诗文, 王诚. 靶向药物联合缺损修复在成人先天性心脏病相关重度肺动脉高压的应用[J/OL]. 中华心脏与心律电子杂志, 2024, 12(02): 86-93.
[8] 赵伟伟, 赵玉华, 刘小璇. 西藏地区亚甲基四氢叶酸还原酶C677T多态性及其与脑微出血的相关性[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 473-478.
[9] 吴娟娟, 彭斌, 倪俊. 脑淀粉样血管病疾病修饰治疗研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 375-381.
[10] 董立羚, 王添艺, 毛晨晖, 姜宇涵, 尚丽, 包嘉璐, 仇宇悦, 褚珊珊, 金蔚, 倪俊, 高晶. 非出血型脑淀粉样血管病的认知特征——来自北京协和医院痴呆队列的数据[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 295-300.
[11] 沙宇惠, 梁梦琳, 贾琛皓, 吴娟娟, 张天昊, 朱以诚, 崔瑞雪, 倪俊. 脑淀粉样血管病β淀粉样蛋白沉积特征及其与影像学标志物的关系[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 301-308.
[12] 周雅萍, 洪月慧, 苏宁, 刘暴, 朱铁楠, 倪俊. 脑淀粉样血管病合并易栓状态的临床治疗决策[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 338-344.
[13] 颜庭梦, 徐佳洁, 董强, 程忻. 医源性脑淀粉样血管病的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 370-374.
[14] 欧春影, 李晓宾, 郭靖, 许可, 王梦, 安晓雷. hs-CRP、Lp-PLA2和S100β与缺血性脑小血管病患者认知障碍的相关性[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(03): 265-269.
[15] 王梦欣, 李莫凡, 王淑敏. 脑微循环成像技术在脑小血管病中的应用研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(03): 281-284.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?